TWiV 758: COVID-19 clinical update #63 with Dr. Daniel Griffin
May 22, 2021•45 min•Ep. 758
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #63, Daniel Griffin reviews cases at child care facilities, estimates of mRNA vaccine effectiveness, risk of reinfection in university students, enhanced antibody generation with extended interval of mRNA vaccination, no benefit of convalescent plasma in hospitalized patients, and risk of clinical sequelae after acute infection.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- COVID-19 in child care facilities (MMWR)
- mRNA vaccine effectiveness (MMWR)
- Excelsior pass (NYS)
- Risk of SARS-CoV-2 reinfection in university students (CID)
- Enhanced antibody production with longer mRNA vaccine interval (medRxiv)
- Convalescent plasma trial in hospitalized patients (Lancet)
- Phase 3 data on REGEN-COV (PR Newswire)
- Clinical sequelae after acute COVID-19 (BMJ)
- Letters read on TWiV 758
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android